Synthesis of Hydrophobic N'-Mono and N',N"-Double Alkylated Eremomycins Inhibiting the Transglycosylation Stage of Bacterial Cell Wall Biosynthesis.

A. Y. PAVLOV, S. S. Printsevskaya, Eugenia N. Olsufyeva, M. N. Preobrazhenskaya, Robert C. Goldman, Arthur Branstrom, Eugene R. Baizman, Clifford Longley

The Journal of Antibiotics · 2001 · 24 citations · 10 references

DOIFull text

Open access

Concepts

Abstract

A series of hydrophobic N'-mono and N',N"-double alkylated derivatives of the glycopeptide antibiotic eremomycin were synthesized by reductive alkylation after preliminary protection of the N-terminal amino group of the peptide backbone. The investigation of the antibacterial activity in vitro showed that N'-C10H21- and N'-p-(p-chlorophenyl)benzyl derivatives of eremomycin are the most active against vancomycin-resistant enterococci among the compounds obtained though they are less effective than the corresponding lipophilic derivatives of vancomycin. The introduction of two hydrophobic substituents led to a decrease in activity against both susceptible and resistant bacteria. The biochemical evaluation of the mode of action revealed that in addition to binding to D-Ala-D-Ala these compounds also have an alternative mechanism of action that does not require substrate binding.

References

10